Christopher L Lynch

USPTO Granted Patents = 31 (Patent Applications = 1)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 5)

Average Co-Inventor Count = 7.5

ph-index = 15

Forward Citations = 810(Granted Patents)

Location History:

Scotch Plains, NJ (US) (2000 - 2009)
Trevor, WI (US) (2007 - 2015)
Philadelphia, PA (US) (2020 - 2022)

Company Filing History:

13 out of 4,177

Abbott Laboratories Corporation

Years Active: 2000-2024

Loading Chart...

31 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12091253 - Automated storage and retrieval system with detector for detecting items extending beyond dimensional threshold (2024-09-17),

2. 11319149 - Automated storage and retrieval system with detector for detecting items extending beyond dimensional threshold (2022-05-03),

3. 10589930 - Automated storage and retrieval system with detector for detecting items extending beyond dimensional threshold (2020-03-17),

4. 9045444 - Apoptosis promoters (2015-06-02),

5. 8686136 - Apoptosis promoters (2014-04-01),

6. 8614318 - Apoptosis promoters (2013-12-24),

7. 8609713 - Pyrrole derivatives and their methods of use (2013-12-17),

8. 8470813 - Thiazoline and oxazoline derivatives and their methods of use (2013-06-25),

9. 8354404 - Apoptosis promoters (2013-01-15),

10. 8173811 - Apoptosis promoters (2012-05-08),

11. 8084607 - Apoptosis promoters (2011-12-27),

12. 7973161 - Apoptosis promoters (2011-07-05),

13. 7906505 - Apoptosis promoters (2011-03-15),

14. 7872017 - Fused bicycloheterocycle substituted azabicyclic alkane derivatives (2011-01-18),

15. 7777076 - Macrocyclic inhibitors of BCL proteins (2010-08-17),

Title: Christopher L Lynch: Innovator in Apoptosis Promoters

Introduction: Christopher L Lynch, based in Trevor, Wisconsin, is a prolific inventor with a remarkable portfolio of 28 patents. His work focuses primarily on the development of compounds that target anti-apoptotic proteins, contributing significantly to medical sciences.

Latest Patents: Among his latest patents, Lynch has disclosed innovative compounds designed to inhibit the activity of anti-apoptotic protein family members. These compounds, which are integral to compositions for preparing medicaments, play a crucial role in treating diseases associated with the expression of these proteins. This innovative approach demonstrates his commitment to advancing therapeutic strategies in critical medical areas.

Career Highlights: Throughout his career, Lynch has been associated with notable companies, including Abbott Laboratories and Merck & Company. His expertise in pharmaceuticals and biochemistry has led to significant advancements in the field, particularly concerning therapeutic options for various diseases.

Collaborations: Lynch has collaborated with esteemed colleagues such as Xilu Wang and Hong Ding. Their combined expertise has undoubtedly contributed to the success of their projects and the development of impactful inventions.

Conclusion: Christopher L Lynch stands out as an influential inventor in the field of apoptosis promoters. His contributions through innovative patents and collaborations highlight the importance of research and development in creating effective medical treatments. With his ongoing work, Lynch continues to pave the way for advancements in therapeutic options that can potentially change lives.

This text is generated by artificial intelligence and may not be accurate.